Cite
MLA Citation
Shihchen Kuo et al.. “Are the favorable cardiovascular outcomes of empagliflozin treatment explained by its effects on multiple cardiometabolic risk factors? A simulation of the results of the EMPA-REG OUTCOME trial.” Diabetes research and clinical practice, vol. 141, 2018, pp. 181–189. http://access.bl.uk/ark:/81055/vdc_100066135655.0x000029